/MEDIF
MEDIF Stock - MediPharm Labs Corp.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.05+1.53%
+$0.00 (+1.53%) • Dec 19
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.49
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.83
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.06
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MEDIF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.05 – $0.05
TARGET (TP)$0.06
STOP LOSS$0.05
RISK/REWARD1:2.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.93
52W High$0.09
52W Low$0.04
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $41.96M | $33.06M | $22.12M | $21.71M | $36.01M |
| Gross Profit | $12.80M | $5.86M | $-1,914,000 | $-15,246,000 | $-43,978,000 |
| Gross Margin | 30.5% | 17.7% | -8.7% | -70.2% | -122.1% |
| Operating Income | $-10,809,000 | $-18,252,000 | $-29,533,000 | $-48,916,000 | $-72,576,000 |
| Net Income | $-10,694,000 | $-13,083,000 | $-29,983,000 | $-54,801,000 | $-67,110,000 |
| Net Margin | -25.5% | -39.6% | -135.6% | -252.4% | -186.4% |
| EPS | $-0.03 | $-0.04 | $-0.11 | $-0.22 | $-0.48 |
Company Overview
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MEDIFBeat Rate
13%
Last 16 quarters
Avg Surprise
-126.7%
EPS vs Estimate
Beats / Misses
2/14
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q1 24
+15.2%
$-0.01vs$-0.01
Q2 24
-10.2%
$-0.01vs$-0.01
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
-505.5%
$-0.01vs$-0.00
Q4 25
-69.8%
$-0.00vs$-0.00
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | $-0.00 | $-0.00 | -69.8% | ✗ MISS |
Q3 2025 | Aug 14, 2025 | $-0.00 | $-0.01 | -505.5% | ✗ MISS |
Q2 2025 | May 14, 2025 | — | $-0.00 | — | — |
Q1 2025 | Mar 27, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 15, 2024 | $-0.01 | $-0.01 | -10.2% | ✗ MISS |
Q1 2024 | Mar 27, 2024 | $-0.01 | $-0.01 | +15.2% | ✓ BEAT |
Q4 2023 | Nov 14, 2023 | $-0.00 | $-0.01 | -157.3% | ✗ MISS |
Q3 2023 | Aug 14, 2023 | $-0.01 | $-0.01 | +53.9% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | $-0.01 | $-0.02 | -33.3% | ✗ MISS |
Q1 2023 | Mar 27, 2023 | $-0.01 | $-0.01 | -20.4% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Q3 2022 | Aug 15, 2022 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Q2 2022 | May 16, 2022 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Q1 2022 | Mar 31, 2022 | $-0.02 | $-0.08 | -300.0% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Q3 2021 | Aug 16, 2021 | $-0.03 | $-0.05 | -66.7% | ✗ MISS |
Q2 2021 | May 17, 2021 | $-0.03 | $-0.07 | -133.3% | ✗ MISS |
Q1 2021 | Mar 31, 2021 | $-0.03 | $-0.21 | -600.0% | ✗ MISS |
Latest News
MediPharm Labs Q3 EPS $(0.01), Same YoY, Sales $11.448M Miss $12.413M Estimate
📉 NegativeBenzinga•Nov 13, 2025, 01:11 PM
MediPharm Labs Q3 EPS $(0.01), Same YoY, Sales $8.315M Up From $7.182M YoY
➖ NeutralBenzinga•Nov 13, 2025, 01:08 PM
MediPharm Labs Q3 Sales $8.315M Up From $7.182M YoY
📈 PositiveBenzinga•Nov 13, 2025, 01:06 PM
Frequently Asked Questions about MEDIF
What is MEDIF's current stock price?
MediPharm Labs Corp. (MEDIF) is currently trading at $0.05 per share. The stock has moved +1.53% today.
What is the analyst price target for MEDIF?
No analyst price targets are currently available for this stock.
What sector is MediPharm Labs Corp. in?
MediPharm Labs Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is MEDIF's market cap?
MediPharm Labs Corp. has a market capitalization of $0.02 billion, making it a small-cap company.
Does MEDIF pay dividends?
No, MediPharm Labs Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAVCNF
Avicanna Inc.
$0.17
Mkt Cap: $0.0B
CAAOF
INDVR Brands Inc.
$0.00
Mkt Cap: $0.0B
CHOOF
Choom Holdings Inc.
$0.00
Mkt Cap: $0.0B
CWBHF
Charlotte's Web Holdings, Inc.
$0.21
Mkt Cap: $0.0B
EVRRF
Molecule Holdings Inc.
$0.00
Mkt Cap: $0.0B
GBLP
Global Pharmatech, Inc.
$0.05
Mkt Cap: $0.0B
ISCNF
Isracann Biosciences Inc.
$0.00
Mkt Cap: $0.0B
RAPH
Raphael Pharmaceutical Inc.
$1.40
Mkt Cap: $0.0B
RVXCF
Resverlogix Corp.
$0.07
Mkt Cap: $0.0B
VYYRF
Voyageur Pharmaceuticals Ltd.
$0.10
Mkt Cap: $0.0B
Explore stocks similar to MEDIF for comparison